Sirio Pharma Co., Ltd. (SHE:300791)
China
· Delayed Price · Currency is CNY 20.55
-0.47 (-2.24%)
At close: Mar 9, 2026
Sirio Pharma Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Operating Revenue | 4,426 | 4,184 | 3,568 | 2,493 | 2,331 | 2,029 | Upgrade
|
| Other Revenue | 27.4 | 27.4 | 13.91 | 14.19 | 38.01 | 37.42 | Upgrade
|
| Revenue | 4,454 | 4,211 | 3,582 | 2,507 | 2,369 | 2,067 | Upgrade
|
| Revenue Growth (YoY) | 7.90% | 17.56% | 42.87% | 5.84% | 14.62% | 30.85% | Upgrade
|
| Cost of Revenue | 3,023 | 2,891 | 2,498 | 1,737 | 1,604 | 1,405 | Upgrade
|
| Gross Profit | 1,430 | 1,320 | 1,085 | 770.42 | 764.94 | 661.56 | Upgrade
|
| Selling, General & Admin | 868 | 770.86 | 628.44 | 428.27 | 385.27 | 306.64 | Upgrade
|
| Research & Development | 127.82 | 125.94 | 110.49 | 80.72 | 83.19 | 64.71 | Upgrade
|
| Other Operating Expenses | -4.46 | -6.48 | -35.8 | 14.85 | 14.4 | 12.82 | Upgrade
|
| Operating Expenses | 995.05 | 890.64 | 708.19 | 527.83 | 483.83 | 387.71 | Upgrade
|
| Operating Income | 435.24 | 429.2 | 376.33 | 242.59 | 281.11 | 273.85 | Upgrade
|
| Interest Expense | -97.3 | -95.03 | -78.48 | -42.77 | -13.93 | -1.8 | Upgrade
|
| Interest & Investment Income | 7.39 | 6.89 | 9.24 | 34.97 | 32.18 | 20.33 | Upgrade
|
| Currency Exchange Gain (Loss) | 10.86 | 10.86 | 20.31 | 25.49 | -18.17 | -3.96 | Upgrade
|
| Other Non Operating Income (Expenses) | -7 | -2.87 | -1.28 | -1.47 | -1.25 | -1.6 | Upgrade
|
| EBT Excluding Unusual Items | 349.19 | 349.05 | 326.11 | 258.81 | 279.96 | 286.82 | Upgrade
|
| Gain (Loss) on Sale of Investments | -28.08 | -26.72 | -57.67 | -1.64 | -1.05 | 3.95 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.47 | 0.24 | 0.03 | -5.51 | 0.15 | -0.01 | Upgrade
|
| Asset Writedown | -11.39 | -4.41 | -0.95 | - | -1.86 | -1.39 | Upgrade
|
| Other Unusual Items | 19.47 | -1.51 | 5.73 | -0.15 | 3.7 | 22.59 | Upgrade
|
| Pretax Income | 329.66 | 316.65 | 273.26 | 251.52 | 280.9 | 311.96 | Upgrade
|
| Income Tax Expense | 38.53 | 34.64 | 32.97 | 39.23 | 49.07 | 54.6 | Upgrade
|
| Earnings From Continuing Operations | 291.13 | 282.02 | 240.29 | 212.29 | 231.83 | 257.37 | Upgrade
|
| Minority Interest in Earnings | 54.4 | 43.04 | 40.75 | - | - | - | Upgrade
|
| Net Income | 345.53 | 325.06 | 281.04 | 212.29 | 231.83 | 257.37 | Upgrade
|
| Net Income to Common | 345.53 | 325.06 | 281.04 | 212.29 | 231.83 | 257.37 | Upgrade
|
| Net Income Growth | 2.93% | 15.66% | 32.39% | -8.43% | -9.92% | 80.58% | Upgrade
|
| Shares Outstanding (Basic) | 305 | 304 | 305 | 304 | 304 | 304 | Upgrade
|
| Shares Outstanding (Diluted) | 305 | 304 | 305 | 307 | 322 | 306 | Upgrade
|
| Shares Change (YoY) | 0.24% | -0.36% | -0.82% | -4.47% | 5.00% | 23.77% | Upgrade
|
| EPS (Basic) | 1.13 | 1.07 | 0.92 | 0.70 | 0.76 | 0.85 | Upgrade
|
| EPS (Diluted) | 1.13 | 1.07 | 0.92 | 0.69 | 0.72 | 0.84 | Upgrade
|
| EPS Growth | 2.68% | 16.08% | 33.48% | -4.15% | -14.21% | 45.89% | Upgrade
|
| Free Cash Flow | 206.27 | 154.84 | -65.62 | 151.17 | -183.31 | 96.43 | Upgrade
|
| Free Cash Flow Per Share | 0.68 | 0.51 | -0.21 | 0.49 | -0.57 | 0.32 | Upgrade
|
| Dividend Per Share | 0.500 | 0.500 | 0.651 | 0.207 | 0.237 | 0.237 | Upgrade
|
| Dividend Growth | -23.18% | -23.18% | 214.29% | -12.50% | - | 200.00% | Upgrade
|
| Gross Margin | 32.11% | 31.34% | 30.28% | 30.73% | 32.29% | 32.01% | Upgrade
|
| Operating Margin | 9.77% | 10.19% | 10.51% | 9.68% | 11.87% | 13.25% | Upgrade
|
| Profit Margin | 7.76% | 7.72% | 7.85% | 8.47% | 9.79% | 12.45% | Upgrade
|
| Free Cash Flow Margin | 4.63% | 3.68% | -1.83% | 6.03% | -7.74% | 4.67% | Upgrade
|
| EBITDA | 589.63 | 612.03 | 597.06 | 366.95 | 379.29 | 353.57 | Upgrade
|
| EBITDA Margin | 13.24% | 14.53% | 16.67% | 14.64% | 16.01% | 17.11% | Upgrade
|
| D&A For EBITDA | 154.4 | 182.83 | 220.73 | 124.36 | 98.18 | 79.72 | Upgrade
|
| EBIT | 435.24 | 429.2 | 376.33 | 242.59 | 281.11 | 273.85 | Upgrade
|
| EBIT Margin | 9.77% | 10.19% | 10.51% | 9.68% | 11.87% | 13.25% | Upgrade
|
| Effective Tax Rate | 11.69% | 10.94% | 12.06% | 15.60% | 17.47% | 17.50% | Upgrade
|
| Revenue as Reported | 4,454 | 4,211 | 3,582 | 2,507 | 2,369 | 2,067 | Upgrade
|
| Advertising Expenses | - | 12.17 | 7.8 | 11.73 | 31.9 | 11.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.